HARVONI is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV nucleotide analog NS5B polymerase inhibitor, and is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of HARVONI (ledipasvir and sofosbuvir) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the HARVONI (ledipasvir and sofosbuvir) tablets medicine cost price in India.
The order for HARVONI (ledipasvir and sofosbuvir) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. Some evidence also supports use in HCV genotype 3 and 4. It is taken daily by mouth for 8–24 weeks.
HARVONI (ledipasvir and sofosbuvir) tablets, for oral use Initial U.S. Approval: 2014
Generic Name: ledipasvir and sofosbuvir
Tablets: 90 mg ledipasvir and 400 mg sofosbuvir.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand HARVONI (ledipasvir and sofosbuvir) tablets on prescription and Import License in Patient's Name only.
For overseas patients, HARVONI (ledipasvir and sofosbuvir) tablets can be made available in Send your enquiry to find HARVONI (ledipasvir and sofosbuvir) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For HARVONI (ledipasvir and sofosbuvir) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Natco Pharma launches Hepcinat Plus in India For More Details
FDA approves two hepatitis C drugs for pediatric patients For More Details